Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
Leveraging Health Information Technology to Reduce Health Disparities in Adolescent Health Outcomes: A Patient-Centered Approach
1 other identifier
interventional
270
1 country
1
Brief Summary
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2020
CompletedFirst Posted
Study publicly available on registry
May 4, 2020
CompletedStudy Start
First participant enrolled
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
August 21, 2024
August 1, 2024
3 years
April 30, 2020
August 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
STI treatment adherence
Proportion of study participants who complete their medication as prescribed by self-report
1-21 days after prescription filling
Secondary Outcomes (1)
STI treatment receipt
1-21 days after STI diagnosis
Study Arms (2)
mHealth
OTHERAdolescents enrolled in this arm will receive treatment-related text messages.
Usual care
NO INTERVENTIONAdolescents in this arm will receive usual care.
Interventions
Adolescents will receive text messages to facilitate treatment adherence
Eligibility Criteria
You may qualify if:
- Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.
You may not qualify if:
- Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's National Hospital
Washington D.C., District of Columbia, 20016-1838, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Monika Goyal
Children's National Research Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Pediatrics and Emergency Medicine
Study Record Dates
First Submitted
April 30, 2020
First Posted
May 4, 2020
Study Start
June 3, 2024
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
August 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share